The NIH awarded $65 million grant to Institute for Translational Health Sciences to turn promising discoveries into patient care advances
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
-
-
The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands Government
On Jul. 4, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…
-
The CDC responded to a multi-state outbreak of salmonella infections associated with raw tuna
On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…
-
Rocky Mountain Biological Laboratory announced $10 million legacy campaign
On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…
-
Biotechnology | Disease | FDA | Vaccine
FDA approved HibMenCY vaccine for infants
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
-
Biotechnology | Infectious Disease | Polio | Vaccine | WHO
The European Region of the world was certified as polio-free
On Jun. 21, 2012, the European Region of the world was certified as polio-free. Certification followed years of…
-
The Human Microbiome Project milestone announced
On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….
-
Scientists decoded genome of bonobo
On Jun. 13, 2012, in a project led by the Max Planck Institute for Evolutionary Anthropology in Leipzig,…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
-
Scientists decoded genome of Chagas disease
On Jun. 5, 2012, an international team of scientists decoded genome of Chagas disease. Previously, scientists had only…
-
U.S. Dept of HHS Inspector General released report titled “Vaccines for Children Program: Vulnerabilities in Vaccine Management”
On Jun. 5, 2012, the U.S. Department of Health and Human Services (HHS) Office of the Inspector General…
-
First patent application granted for CRISPR-Cas9 gene editing in all environments
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
-
AZBio led a cross industry coalition to amend Arizona’s Open Records Law
May 22, 2012, AZBio led a cross industry coalition to amend Arizona’s Open Records Law to make the…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approved orphan drug Elelyso to treat a form of Gaucher disease
On May 1, 2012, Pfizer and Protalix BioTherapeutics announced that the U.S. Food and Drug Administration (FDA) had approved…
-
Hologic acquired Gen-Probe for $3.7 billion
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
-
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
-
Biotechnology | Diagnostics | Medicine | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
The Golden Goose Award was founded
On Apr. 25, 2012, U.S. Representatives Jim Cooper (D-Tenn.), Charlie Dent (R-Pa.), and Robert J. Dold (R-Ill.) joined…
-
The USDA confirmed detection of Bovine Spongiform Encephalopathy (BSE) in California
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
-
Biotechnology | FDA | Infectious Disease | NIH | Vaccine
Washington State Secretary of Health declared a pertussis epidemic, Worst Since 1942
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. U.S. Since mid-2011, a…
-
Biotechnology | CDC | Oncology | Therapeutics
Report to the nation finds continuing declines in cancer death rates since the early 1990s
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
-
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
-
OHSU-led consortium awarded $21 million grant to study alcoholism, stress
On Mar. 8, 2012, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a five-year, $21 million…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
Draft sequence of the gorilla genome was published
On Mar. 7, 2012, an international team led by researchers at the Wellcome Trust Sanger Institute announced they…
-
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
-
Biotechnology | Diagnostics | Infectious Disease | Influenza | Non-Profit Research | Therapeutics | Vaccine
Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
-
Biotechnology | Disease | FDA | Therapeutics
The FDA approved Korlym for patients with endogenous Cushing’s syndrome
On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…
-
Entire genome of extinct Denisovan human decoded from fossil
On Feb. 7, 2012, The Max Planck Institute for Evolutionary Anthropology, in Leipzig, Germany, completed the genome sequence…
-
The FDA approved KALYDECO (ivacaftor) to treat the genetic mechanism of cystic fibrosis
On Jan. 31, 2012, Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved KALYDECOTM…
-
Biotechnology | FDA | Oncology | Therapeutics
The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
-
The UC San Diego Health System acquired the Nevada Cancer Institute
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
